On this page
Cinryze
C1 Esterase Inhibitor (Human)
351(a) Standalone BLA
Overview
Source: Purple BookProprietary name
Cinryze
Proper name
C1 Esterase Inhibitor (Human)
Licence type
351(a)
BLA number
125267
Applicant
Takeda Pharmaceuticals U.S.A., Inc.
Center
CBER
Presentations
1
First licensure
—
Presentations
Source: Purple Book| Strength | Dosage form | Route | Presentation | Status | Licensed |
|---|---|---|---|---|---|
| 500U | For Injection | Intravenous | Single-Dose Vial | Rx | October 10, 2008 |
Exclusivity
Source: Purple Book| Kind | Expires |
|---|---|
| Orphan exclusivity | June 20, 2025 |
Sources for this page
| Purple Book | FDA | Licence type, presentations, reference product, exclusivity |